News

COMING SOON. DIA Europe 2020, 17th-19th March 2020, Brussels

DIA (Drug Information Association) bring together its members to collaborate on and discuss global and local challenges facing the life sciences field in an increasingly more complex and interconnected world. DIA Europe 2020 is the largest and most forward-looking neutral healthcare conference in Europe. This annual healthcare meeting reflects DIA’s strategic initiatives across several Thought

December 13th, 2019|

COMING SOON. RESTORE Momentum Workshop, 17th February 2020, Berlin

On 17th February 2020 the RESTORE Momentum Workshop will take place in Berlin and will welcome RESTORE supporters and partners. TEDDY Network is involved in RESTORE as supporter, a large-scale Research Initiative with the scope to create a consortium aimed to build a coordinated, financially strong, academia-industry partnership in order to tackle the main interdisciplinary

December 13th, 2019|

COMING SOON. EFGCP & EFPIA Workshop “Roadmap Initiative to Good Lay Summary Practices”, 15 January 2020, Bruxelles

On 15 January 2020, the EFGCP & EFPIA Workshop "Roadmap Initiative to Good Lay Summary Practices” will be held in Brussels. The upcoming Clinical Trial Regulation requires the development and dissemination of Lay Summaries of clinical study results from commercial and non-commercial sponsors. EMA has released an Expert Group Recommendation on the content of Lay

December 13th, 2019|

FDA approves voxelotor for sickle cell disease

On November 25th, 2019, the Food and Drug Administration (FDA) granted accelerated approval to voxelotor (Oxbryta, Global Blood Therapeutics) for adults and paediatric patients 12 years of age older with sickle cell disease (SCD). SCD is a lifelong inherited blood disorder caused by a genetic mutation in the beta-chain of haemoglobin (HbS). Mutated HbS has

December 12th, 2019|

Vincristine shortage: an overview on the current European situation

Over the last months, a worrying shortage in the production and distribution of vincristine has affected the health marketplace across the world. Vincristine is an antineoplastic drug, a natural extract from the periwinkle (Cantharanthus roseus, formerly Vinca rosea), which is a species of myrtle. Vincristine is an antitumor drug hugely used in the care of

December 12th, 2019|

A new year of activities for KIDS Bari and KIDS Albania has started

We are happy to announce that even this year the youths of KIDS Bari and KIDS Albania have kicked off their activities aimed to promote the involvement of young persons and patients in the research and clinical fields strongly favouring the achievement of goals in the paediatric drug development and availability. The healthy youths and

December 12th, 2019|

Clinical Trials Europe, 20th November 2019: TEDDY efforts to promote patient’s engagement were presented

On 19th and 20th November 2019, the Annual meeting “Clinical Trials Europe” was held in Barcelona and provided the occasion to bring the clinical community together. The participants had the possibility to share and discuss fresh perspectives and practises for clinical management, patient centricity, drug development operating environment and digital revolution. TEDDY Network participated in

December 12th, 2019|

Publication: “Survey by TEDDY European Network of Excellence for Paediatric Clinical Research demonstrates potential for Europe‐wide trials”

Ensuring high-quality ethical research on the safety and efficacy of medicines for children represents one of the main objectives of the paediatric sector! However, there are no summary data in the public domain about the capacity and competence of European paediatric centres to carry out research studies. To this end, the TEDDY Network developed and

November 28th, 2019|